top of page

NEWS & INSIGHTS

Dive into the Biopharma Space

Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.

23 recently-funded U.S. clinical stage cancer companies: Target customers for you?

We used our powerful online clinical trial/sponsor search platform at BiopharmIQ.com to identify 23 small (250 employees or less), U.S.-based, companies that are currently recruiting into clinical trials that raised at least $10M in the 1st half of 2024 (see graphic). Not surprisingly, the states with the largest number of these companies were California (9) and Massachusetts (7). We were surprised that the only other state with more than 1 company in this category was New York (4), and that only 3 other states (Connecticut, New Jersey, and Texas) had any companies falling in this category (1 each).


FIG 1: 23 Recently Funding US Clinical Stage Cancer Companies


These companies included public and private companies across many therapeutic categories including small molecules, cell therapies, gene therapies, and more. The amount of funding ranged from $10M (Imunon) all the way up to $184M (Erasca). See the Table below for more details.



With our BiopharmIQ platform you can find new target sponsor customers quickly by combining searches of the entire ClinicalTrials government database, with searches of sponsor details (e.g., location, size private/public, technologies), contact job titles, recent funding and more. Stop wasting your valuable time searching the ClinicalTrials government site directly. Set up a free BiopharmIQ account today.


Watch a short demo video of our platform and see our online platform in action. Get instant access to all our data/modules: Check out our affordable pricing plans, which come with a satisfaction guarantee.


Have questions or want to schedule an online demo?



***


Article History:

MV (8/15/24)


Not legal, investing or tax advice.

Comments


bottom of page